Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Author(s) -
Rik Ossenkoppele,
Gil D. Rabinovici,
Ruben Smith,
Hanna Cho,
Michael Schöll,
Olof Strandberg,
Sebastian Palmqvist,
Niklas Mattsson,
Shorena Janelidze,
Alexander Santillo,
Tomas Ohlsson,
Jonas Jögi,
Richard Tsai,
Renaud La Joie,
Joel H. Kramer,
Adam L. Boxer,
Maria Luisa GornoTempini,
Bruce L. Miller,
Jae Yong Choi,
Young Hoon Ryu,
Chul Hyoung Lyoo,
Oskar Hansson
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.12917
Subject(s) - medicine , positron emission tomography , dementia , magnetic resonance imaging , standardized uptake value , nuclear medicine , alzheimer's disease , cognitive impairment , disease , radiology
The positron emission tomography (PET) tracer [18F]flortaucipir allows in vivo quantification of paired helical filament tau, a core neuropathological feature of Alzheimer disease (AD), but its diagnostic utility is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom